Life sciences teams should start with a unified view of sensitive data across structured, semi-structured, and unstructured sources. Then they can classify what is regulated, reduce redundant copies, prioritize the most valuable records, and enforce policies tied to sensitivity, location, and access. That approach helps reduce attack surface, support compliance, and improve response when a breach or misuse occurs.
Building a data-centric strategy around the data itself
A data-centric security strategy starts by treating sensitive information as the security boundary, not the application, storage platform, or user interface around it. For life sciences teams, that means building an accurate inventory of regulated data and IP across research, clinical, regulatory, manufacturing, and commercial environments, then attaching policy to the data wherever it moves.
This approach matters because the same dataset can exist in databases, file shares, collaboration tools, lab systems, analytics platforms, and partner exchanges. If teams only secure infrastructure, they miss the copies, exports, and derived artifacts that often create the real exposure.
That inventory is also where data governance becomes operational. Once you know what is sensitive, you can distinguish regulated records from ordinary business content, remove unnecessary duplication, and focus protection on the data that would cause the most harm if exposed, altered, or lost.
How classification, minimization, and location-aware controls work together
Classification is the control that makes data-centric security practical. It gives teams a way to assign handling rules to trade secrets, clinical data, submissions, formulas, trial records, and other high-value material without relying on ad hoc judgement at every touchpoint.
Minimization then reduces the blast radius. When redundant copies are deleted, deduplicated, or moved out of general use, teams lower the number of places an attacker, careless user, or misrouted process can reach. In regulated environments, that also makes retention and deletion decisions easier to defend.
Location-aware policy enforcement is the next step. Sensitive data often needs different treatment depending on where it sits, who can reach it, and whether it is moving to a lower-trust environment. Good controls tie access, sharing, export, masking, and encryption to the data's sensitivity and context rather than to a single system boundary.
Why life sciences needs a unified view of regulated data and IP
Life sciences programs typically span structured records, semi-structured lab outputs, and unstructured documents such as protocols, reports, and correspondence. That diversity makes a unified view essential, because sensitive content is often split across formats and repositories that were never designed to be governed as one exposure surface.
For regulated data, this supports compliance and evidence retention. For IP, it supports selective protection of formulas, target profiles, assay results, and other crown-jewel content that may not be regulated in the same way but still carries severe competitive value. The practical goal is not just visibility, but prioritization: teams should know which records warrant the strongest controls and fastest response.
External guidance on data governance and privacy supports this pattern, including the EU General Data Protection Regulation (GDPR) for personal data handling and the NIST Privacy Framework for data governance and risk management. Where sensitive research or product data is treated as part of a broader security program, the NIST Cybersecurity Framework 2.0 helps connect inventory, protection, detection, response, and recovery.
Risk and Threat Considerations
Life sciences data programs fail when sensitive material is easy to copy, hard to classify, or spread across too many repositories to govern consistently. The result is usually not one dramatic event, but chronic exposure through over-retention, uncontrolled sharing, and weak visibility into where regulated data or IP actually lives.
Failure mechanism: Sensitive records remain duplicated across systems, escape classification, or inherit permissive access from the host environment instead of the data itself. That creates a large attack and misuse surface, especially when collaboration, outsourcing, or analytics workflows move information outside the original control domain.
Impact: Organizations can lose confidentiality, fail to enforce retention or disclosure requirements, and slow incident response because they cannot quickly determine what was exposed, where it was copied, or which records need immediate containment.
Standards & Framework Alignment
This section maps relevant standards and security frameworks to the operational risks and controls described in this guidance.
NIST CSF 2.0 and NIST SP 800-53 Rev 5 set the technical controls, while GDPR defines the regulatory obligations.
| Framework | Control / Reference | Relevance |
|---|---|---|
| GDPR | A.5 — Data Protection Principles | Life sciences regulated data often includes EU personal data that needs purpose limitation and minimization. |
| A.32 — Security of Processing | Data-centric protection needs confidentiality and access controls tied to sensitive records. | |
| A.25 — Data Protection by Design and by Default | Classification and location-aware controls are design-time privacy controls for regulated data. | |
| Recommendation — Apply data minimization and purpose limits to regulated datasets before broad sharing or secondary use. Use appropriate technical and organisational measures to protect sensitive data according to risk. Build privacy and access safeguards into data workflows by default, not as afterthoughts. | ||
| NIST CSF 2.0 | ID.AM-08 — Cybersecurity Supply Chain Risk Management | Life sciences data moves through vendors, labs, and partners, so dependency visibility matters. |
| PR.DS-01 — Data-at-rest is protected | Sensitive research and regulated records need protective controls wherever they are stored. | |
| PR.DS-10 — Data in transit is protected | Data-centric controls must follow sensitive content as it moves between systems and partners. | |
| Recommendation — Map sensitive data flows across third parties and apply stronger controls to external transfers. Protect stored regulated data and IP with encryption, access limits, and monitored storage paths. Protect sensitive data in transfer with secure channels and controlled exchange paths. | ||
| NIST SP 800-53 Rev 5 | AC-6 — Least Privilege | Data-centric security depends on limiting access to sensitive records by need-to-know. |
| AU-6 — Audit Record Review, Analysis, and Reporting | Visibility into sensitive data use is required to detect misuse and support investigations. | |
| CM-8 — System Component Inventory | A unified view of sensitive data depends on knowing where repositories and copies exist. | |
| Recommendation — Restrict access to regulated data and IP to the minimum privileges needed for each role. Review sensitive-data access and sharing logs for anomalies and evidence of misuse. Maintain an inventory of systems and repositories that store or process regulated data and IP. | ||
Practitioner Guidance
What to prioritise: Start with the highest-value regulated datasets and IP repositories, then expand to adjacent copies and derived outputs. In practice, the first win is usually not broader monitoring, but fewer uncontrolled data locations.
What to verify: Confirm that classification is actually driving policy decisions for access, export, sharing, retention, and masking. If teams can label data but the label does not change how the data is handled, the strategy is cosmetic.
Decision rule: If a dataset can be replicated, forwarded, or analysed outside the original system, treat copy control and location-aware enforcement as part of the security baseline, not as an optional hardening step.
Practitioner takeaway: A strong life sciences data-centric strategy is judged by whether it can reduce data sprawl and make sensitive records easier to govern in motion, not just easier to find.
Related resources from NHI Mgmt Group
- How should security teams build a data security strategy for code and application data in the SDLC?
- How should security teams build a data catalog strategy that actually gets adopted across the business?
- How should security teams build a cloud data management strategy that balances security, compliance, and agility?
- How should education institutions build a data-centric security strategy for hybrid environments?
Deepen Your Knowledge
Reviewed and updated by the NHIMG editorial team on September 26, 2026.
NHI Mgmt Group — the #1 independent authority on Non-Human Identity, IAM, and Agentic AI security. nhimg.org
